Total Payments
$14,791
2024 Payments
$581.99
Companies
35
Transactions
242
Medicare Patients
4,420
Medicare Billing
$267,507
Payment Breakdown by Category
Consulting$9,195 (62.2%)
Food & Beverage$4,246 (28.7%)
Travel$1,092 (7.4%)
Education$240.42 (1.6%)
Other$18.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,195 | 2 | 62.2% |
| Food and Beverage | $4,246 | 232 | 28.7% |
| Travel and Lodging | $1,092 | 3 | 7.4% |
| Education | $240.42 | 4 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $8,202 | 17 | $0 (2023) |
| Genentech, Inc. | $2,295 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $581.75 | 30 | $0 (2024) |
| Allergan Inc. | $575.57 | 24 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $472.65 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $454.76 | 22 | $0 (2019) |
| GlaxoSmithKline, LLC. | $344.86 | 21 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $246.52 | 14 | $0 (2019) |
| Relypsa, Inc. | $213.21 | 15 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $184.69 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $581.99 | 20 | AstraZeneca Pharmaceuticals LP ($182.72) |
| 2023 | $8,209 | 14 | Genentech USA, Inc. ($8,009) |
| 2022 | $2,379 | 6 | Genentech, Inc. ($2,295) |
| 2021 | $13.54 | 1 | Actelion Pharmaceuticals US, Inc. ($13.54) |
| 2019 | $1,146 | 59 | Allergan Inc. ($242.13) |
| 2018 | $1,304 | 73 | Allergan Inc. ($293.07) |
| 2017 | $1,157 | 69 | Boehringer Ingelheim Pharmaceuticals, Inc. ($186.52) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Immunology | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Education | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.64 | General |
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $94.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/15/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $25.75 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 03/15/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 01/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological), FASENRA, AIRSUPRA | Food and Beverage | In-kind items and services | $67.95 | General |
| Category: Respiratory | ||||||
| 12/20/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $18.75 | General |
| 12/06/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $9.57 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 11/28/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: PAH | ||||||
| 11/17/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $6,900.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,239 | 1,557 | $236,382 | $65,750 |
| 2022 | 10 | 1,336 | 1,828 | $244,210 | $66,633 |
| 2021 | 6 | 869 | 1,316 | $152,743 | $47,449 |
| 2020 | 14 | 976 | 1,416 | $227,265 | $87,676 |
Total Patients
4,420
Total Services
6,117
Medicare Billing
$267,507
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 300 | $57,480 | $27,121 | 47.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 128 | 208 | $52,252 | $12,100 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 70 | 77 | $41,835 | $9,725 | 23.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 39 | $13,137 | $6,413 | 48.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 34 | 36 | $17,208 | $3,557 | 20.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 283 | 294 | $7,350 | $2,630 | 35.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 289 | 300 | $5,408 | $1,992 | 36.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 226 | 233 | $38,212 | $1,777 | 4.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 67 | 70 | $3,500 | $434.80 | 12.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 161 | 381 | $62,424 | $29,285 | 46.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 168 | 399 | $74,623 | $21,351 | 28.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $29,358 | $4,024 | 13.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 295 | 308 | $7,700 | $2,852 | 37.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 27 | 29 | $13,862 | $2,671 | 19.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 298 | 311 | $5,598 | $2,132 | 38.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 256 | 263 | $43,132 | $2,090 | 4.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 37 | $3,933 | $1,532 | 39.0% |
| 94070 | Test to measure lung airway sensitivity | Facility | 2022 | 16 | 16 | $880.00 | $352.27 | 40.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 49 | 54 | $2,700 | $344.00 | 12.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 143 | 572 | $80,310 | $31,221 | 38.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 95 | 107 | $15,408 | $8,376 | 54.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 19 | $15,384 | $2,807 | 18.2% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 207 | 209 | $5,225 | $1,965 | 37.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 198 | 199 | $32,636 | $1,615 | 4.9% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 208 | 210 | $3,780 | $1,465 | 38.7% |
About Dr. Michael Hemphill, MD
Dr. Michael Hemphill, MD is a Internal Medicine healthcare provider based in Duncan, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1255691960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hemphill, MD has received a total of $14,791 in payments from pharmaceutical and medical device companies, with $581.99 received in 2024. These payments were reported across 242 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($9,195).
As a Medicare-enrolled provider, Hemphill has provided services to 4,420 Medicare beneficiaries, totaling 6,117 services with total Medicare billing of $267,507. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Duncan, OK
- Active Since 05/29/2012
- Last Updated 03/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255691960
Products in Payments
- Ocrevus (Biological) $7,992
- OCREVUS (Biological) $2,295
- AVYCAZ (Drug) $501.14
- OFEV (Drug) $316.15
- Adempas (Drug) $246.52
- DUPIXENT (Biological) $245.49
- Veltassa (Drug) $213.21
- FASENRA (Biological) $201.49
- NUCALA (Biological) $132.77
- SYMBICORT (Drug) $105.23
- OPSUMIT (Drug) $104.13
- FASENRA (Drug) $101.81
- TEZSPIRE (Biological) $98.09
- TRELEGY ELLIPTA (Drug) $93.25
- ZERBAXA (Drug) $91.78
- Xolair (Biological) $88.27
- ANORO (Drug) $77.73
- CARDENE (Drug) $75.46
- STIOLTO (Drug) $68.69
- XIFAXAN (Drug) $68.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.